Description:
JADA November 2021
Background. Many people infected with severe acute
respiratory syndrome coronavirus 2 (SARSCoV- 2) never develop substantial
symptoms. With more than 34 million people in the United States already infected
and highly transmissible variants rapidly emerging, it is highly probable that
post- and presymptomatic people will form an
important fraction of those seeking dental care.
Salivary carriage rates in these populations are not known. Moreover, although
preventing transmission is critical for controlling spread, the efficacy of mouthrinses in reducing oral viral
load is poorly
studied.
Keywords. Aerosol; dental; saliva; SARS-CoV-2;
mouthrinse; povidone-iodine; hydrogen peroxide; saline;
chlorhexidine.
